2026 data FDA MAUDE openFDA FDA Class II

Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA Class II (moderate risk, special controls required), regulated under 21 CFR §862.1355 (Clinical Chemistry panel).

FDA MAUDE casebook

openFDA event book Integrated Continuous Glucose Monitoring Sy… HEAVY-BOOK · MAUDE

#24 of 1000 · 165,468 reports · 2020–2026

  • BOOK 165,468 reports
  • RANK #24 of 1000
  • DEATH 29 death-typed
  • INJ 41,805 injury-typed
  • MALF 123,626 malfunction
  • SPAN 2020–2026
  • PEAK 2023: 39,322
  • PHOTO System

Nearest event-volume peer: System, Peritoneal, Automatic Delivery (968 report gap)

Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems sits #24 of 1000 among tracked device types with 165,468 MAUDE reports spanning 2020–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →

Malfunction reports run above the device-type norm

Integrated Continuous Glucose Monitoring Sy… carries 74.7% MALFUNCTION-coded reports, 9.9pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.

  • DEATH 0.0% corpus 1.5% · below corpus mean (-1.5 pp)
  • INJ 25.3% corpus 30.3% · below corpus mean (-5.0 pp)
  • MALF 74.7% corpus 64.8% · above corpus mean (+9.9 pp)

Lead product-problem code Incorrect, Inadequate or Imprecise Result or Readings is 65% of coded problems · Lead manufacturer ABBOTT DIABETES CARE INC accounts for 85% of manufacturer-tagged reports · Top event location is 89% of location-tagged rows .

Integrated Continuous Glucose Monitoring Sy… in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems carries 165,468 MAUDE reports, ranked #24 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Malfunction 123,626 (74.7%)
Injury 41,805 (25.3%)
Death 29 (0.0%)
Other 7 (0.0%)
1 (0.0%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

123,170 (74.7%)
Required Intervention 34,370 (20.8%)
Other 5,604 (3.4%)
R 632 (0.4%)
Hospitalization 628 (0.4%)
H 440 (0.3%)
O 32 (0.0%)
Life Threatening 28 (0.0%)
Death 27 (0.0%)
Disability 16 (0.0%)
L 15 (0.0%)
S 15 (0.0%)
D 2 (0.0%)

Top Product Problems

Incorrect, Inadequate or Imprecise Result or Readings 118,433
Unable to Obtain Readings 18,337
Device Displays Incorrect Message 17,997
Low Readings 6,009
High Readings 5,260
Detachment of Device or Device Component 4,494
Product Quality Problem 3,951
Device Alarm System 3,479
Adverse Event Without Identified Device or Use Problem 2,934
Failure to Power Up 971
Application Program Problem 521
Premature Discharge of Battery 249
Failure to Fire 156
Material Twisted/Bent 139
Activation, Positioning or Separation Problem 132
No Device Output 132
No Audible Alarm 130
Unintended Electrical Shock 115
Power Problem 99
Difficult to Insert 67

Yearly Trend

20
2020: 1,069
21
2021: 22,500
22
2022: 26,528
23
2023: 39,322
24
2024: 35,112
25
2025: 20,527
26
2026: 20,410

Reports fell to 20,527 in 2025, down from an average of 37,217 in the two years before.

Related Entities for Integrated Continuous Glucose Monitoring System, Factory Calibrated, Not For Use With Automated Insulin Delivery Systems

Event Locations

147,116 (88.9%)
I 18,349 (11.1%)
NO INFORMATION 3 (0.0%)

Compare ABBOTT DIABETES CARE INC vs ABBOTT DIABETES CARE LTD →

Nationwide devices with a comparable volume-and-death footprint

Two openFDA-derived peer sets for Integrated Continuous Glucose Monitoring Sy…: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (165,468 here).

Similar death-typed counts

Nearest other device types by death-typed report count (29 here), distinct from the volume row.

Disclaimer: MAUDE figures for Integrated Continuous Glucose Monitoring Sy… are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Integrated Continuous Glucose Monitoring Sy…; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.